MDGL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 23.92%

Insider Buying (Last 12 Months): $43,382,043.47

Insider Selling (Last 12 Months): $40,797,262.98

Madrigal Pharmaceuticals Insider Trading History Chart

Madrigal Pharmaceuticals Share Price & Price History

^$233.49

▼ -8.76 (-3.62%)

As of 09/20/2024 01:00 AM ET

Days: 30 | 90 | 365

Wall Street Insider Issues Crash Prediction

From Stansberry Research | Ad

Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilson, an extremely rare window in the markets is about to open. It's an often-misunderstood market setup we've only seen 13 times since 1920. The last time this happened, it minted a million brand-new millionaires – in a single year. But Tilson says this unique window in the markets could close much sooner than anyone realizes, leaving most investors in the dust, while making a select few incredibly rich.

Get our No. 1 stock (with 500%-plus upside potential) for this rare market event now.

Madrigal Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/9/2024	William John Sibold	CEO	Sell	6,363	$243.83	$1,551,490.29	55,887
6/14/2024	Robert E. Waltermire	VP	Sell	1,900	$280.00	$532,000.00	5,500
6/12/2024	Robert E. Waltermire	VP	Sell	2,000	$285.00	$570,000.00	5,500
5/21/2024	Robert E. Waltermire	VP	Sell	1,036	$231.34	$239,668.24	5,500
5/14/2024	Fred B. Craves	Director	Sell	22,489	$212.88	$4,787,458.32	413,362
4/8/2024	Paul A. Friedman	Director	Sell	26,270	$246.19	$6,467,411.30	185,735
4/8/2024	Rebecca Taub	CMO	Sell	2,676	$245.99	$658,269.24	458,999
4/5/2024	Rebecca Taub	CMO	Sell	27,506	$243.36	$6,693,860.16	458,999
4/4/2024	Paul A. Friedman	Director	Sell	18,710	$242.96	$4,545,781.60	185,735
4/3/2024	Rebecca Taub	CMO	Sell	27,845	$245.14	$6,825,923.30	458,999
4/1/2024	James M. Daly	Director	Sell	32,489	$102.77	$3,338,894.53	1,198
4/1/2024	Richard S. Levy	Director	Sell	11,000	$257.48	$2,832,280.00	10,298
12/13/2023	Bros. Advisors Lp Baker	Director	Buy	81,159	$219.39	$17,805,473.01	1,774,294
12/13/2023	Robert E. Waltermire	VP	Sell	2,500	$225.40	$563,500.00	5,667
12/4/2023	Brian Joseph Lynch	SVP	Sell	1,800	$218.87	$393,966.00	15,001
11/29/2023	Brian Joseph Lynch	SVP	Sell	4,000	$199.19	$796,760.00	15,001
11/21/2023	Bros. Advisors Lp Baker	Director	Buy	64,350	$188.47	$12,128,044.50	1,667,104
11/17/2023	Bros. Advisors Lp Baker	Director	Buy	46,370	$174.70	$8,100,839.00	1,588,541
11/14/2023	Bros. Advisors Lp Baker	Director	Buy	34,188	$156.42	$5,347,686.96	1,531,757
1/17/2023	Richard S. Levy	Director	Sell	22,489	$293.15	$6,592,650.35	9,100
1/3/2023	Brian Joseph Lynch	SVP	Sell	13,000	$282.92	$3,677,960.00
12/23/2022	Brian Joseph Lynch	SVP	Sell	7,000	$274.18	$1,919,260.00
12/23/2022	Remy Sukhija	insider	Sell	30,000	$274.14	$8,224,200.00

Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”

From Paradigm Press | Ad

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…

SEC Filings (Institutional Ownership Changes) for Madrigal Pharmaceuticals (NASDAQ:MDGL)

98.50% of Madrigal Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Madrigal Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/11/2024	Newbridge Financial Services Group Inc.	5,894	$1.65M	0.6%	-46.6%	0.027%
9/5/2024	Sanctuary Advisors LLC	1,051	$0.29M	0.0%	N/A	0.005%
8/27/2024	Dana Investment Advisors Inc.	3,713	$1.04M	0.0%	+13.4%	0.017%
8/21/2024	Truist Financial Corp	772	$0.22M	0.0%	N/A	0.004%
8/19/2024	Point72 Asset Management L.P.	40,958	$11.48M	0.0%	-172.6%	0.189%
8/16/2024	Perceptive Advisors LLC	264,600	$74.13M	1.8%	-38.5%	1.242%
8/16/2024	Creative Planning	3,212	$0.90M	0.0%	+20.0%	0.015%
8/16/2024	Algert Global LLC	1,269	$0.36M	0.0%	N/A	0.006%
8/15/2024	The Manufacturers Life Insurance Company	35,678	$10M	0.0%	+16.1%	0.164%
8/15/2024	AQR Capital Management LLC	4,610	$1.29M	0.0%	-13.1%	0.021%
8/15/2024	Armistice Capital LLC	150,000	$42.02M	0.5%	-10.7%	0.691%
8/15/2024	Affinity Asset Advisors LLC	110,000	$30.82M	3.6%	-4.3%	0.507%
8/15/2024	Paulson & CO. Inc.	1,850,000	$518.30M	38.3%	+4.2%	8.521%
8/14/2024	Fred Alger Management LLC	102,455	$28.70M	0.1%	+58.7%	0.472%
8/14/2024	Marshall Wace LLP	1,700	$0.48M	0.0%	N/A	0.008%
8/14/2024	Tri Locum Partners LP	65,352	$18.31M	4.6%	+22.5%	0.301%
8/14/2024	Xponance Inc.	1,117	$0.31M	0.0%	+25.1%	0.005%
8/14/2024	Avoro Capital Advisors LLC	2,055,555	$575.88M	7.7%	+5.7%	9.468%
8/14/2024	ProShare Advisors LLC	3,298	$0.92M	0.0%	-18.6%	0.015%
8/14/2024	Profund Advisors LLC	6,816	$1.91M	0.1%	+18.3%	0.031%
8/13/2024	Ensign Peak Advisors Inc	83,373	$23.36M	0.0%	-9.6%	0.384%
8/13/2024	Sei Investments Co.	9,799	$2.75M	0.0%	-6.3%	0.045%
8/12/2024	Hsbc Holdings PLC	1,570	$0.44M	0.0%	-93.0%	0.007%
8/12/2024	Vanguard Personalized Indexing Management LLC	728	$0.20M	0.0%	N/A	0.003%
8/12/2024	Amalgamated Bank	607	$0.17M	0.0%	+20.2%	0.003%
8/12/2024	E Fund Management Co. Ltd.	2,212	$0.62M	0.0%	+30.3%	0.010%
8/10/2024	Mutual of America Capital Management LLC	11,348	$3.18M	0.0%	-4.1%	0.053%
8/10/2024	Sofinnova Investments Inc.	44,417	$12.44M	0.6%	+133.4%	0.208%
8/9/2024	AlpInvest Partners B.V.	84,595	$23.70M	8.5%	-20.0%	0.397%
8/8/2024	Envestnet Asset Management Inc.	14,454	$4.05M	0.0%	+198.8%	0.068%
8/8/2024	Oppenheimer Asset Management Inc.	1,476	$0.41M	0.0%	N/A	0.007%
8/8/2024	American Century Companies Inc.	111,113	$31.13M	0.0%	+13.7%	0.521%
8/8/2024	State of New Jersey Common Pension Fund D	8,107	$2.27M	0.0%	-32.4%	0.038%
8/7/2024	Dorsey & Whitney Trust CO LLC	934	$0.26M	0.0%	N/A	0.004%
8/6/2024	Quest Partners LLC	213	$60K	0.0%	+5,225.0%	0.001%
8/6/2024	Emerald Advisers LLC	96,764	$27.11M	1.1%	-4.8%	0.454%
8/5/2024	Arizona State Retirement System	3,525	$0.99M	0.0%	+8.3%	0.017%
8/5/2024	Victory Capital Management Inc.	2,252	$0.63M	0.0%	+5.8%	0.011%
8/3/2024	TD Asset Management Inc	55,730	$15.61M	0.0%	+10.7%	0.261%
8/2/2024	New Harbor Financial Group LLC	718	$0.20M	0.1%	-21.2%	0.003%
8/1/2024	Fiera Capital Corp	115,415	$32.34M	0.1%	N/A	0.532%
8/1/2024	Rhumbline Advisers	25,351	$7.10M	0.0%	+19.9%	0.119%
7/31/2024	Commonwealth Equity Services LLC	2,068	$0.58M	0.0%	+116.8%	0.010%
7/30/2024	Signaturefd LLC	145	$41K	0.0%	+36.8%	0.001%
7/29/2024	Investors Asset Management of Georgia Inc. GA ADV	725	$0.20M	0.1%	-17.1%	0.003%
7/29/2024	Principal Financial Group Inc.	3,056	$0.86M	0.0%	-23.6%	0.014%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	2,444	$0.69M	0.0%	+18.8%	0.011%
7/26/2024	Bank of New York Mellon Corp	73,815	$20.68M	0.0%	+27.5%	0.346%
7/25/2024	Calamos Advisors LLC	4,112	$1.15M	0.0%	+13.8%	0.019%
7/25/2024	AMI Asset Management Corp	5,485	$1.54M	0.1%	-43.0%	0.026%
7/20/2024	China Universal Asset Management Co. Ltd.	2,504	$0.70M	0.1%	-34.1%	0.012%
7/20/2024	First Horizon Advisors Inc.	104	$29K	0.0%	+1,633.3%	0.000%
7/20/2024	Hennion & Walsh Asset Management Inc.	20,337	$5.70M	0.3%	-37.1%	0.095%
7/19/2024	Raymond James & Associates	20,321	$5.69M	0.0%	+0.2%	0.095%
7/18/2024	Assenagon Asset Management S.A.	5,831	$1.63M	0.0%	-55.0%	0.027%
7/16/2024	Envestnet Portfolio Solutions Inc.	898	$0.25M	0.0%	N/A	0.004%
5/30/2024	EULAV Asset Management	11,000	$2.94M	0.1%	-15.4%	0.052%
5/28/2024	Verity Asset Management Inc.	1,574	$0.42M	0.2%	-41.5%	0.007%
5/24/2024	Cetera Advisors LLC	1,051	$0.28M	0.0%	N/A	0.005%
5/17/2024	Artal Group S.A.	110,507	$29.51M	0.8%	N/A	0.519%
5/17/2024	Rokos Capital Management LLP	37,762	$10.06M	0.1%	N/A	0.177%
5/17/2024	Comerica Bank	372	$99K	0.0%	+615.4%	0.002%
5/17/2024	Castleark Management LLC	9,210	$2.46M	0.1%	N/A	0.043%
5/16/2024	Janus Henderson Group PLC	2,601,282	$694.53M	0.4%	-10.4%	12.207%
5/16/2024	Bain Capital Life Sciences Investors LLC	196,995	$52.61M	4.2%	-39.3%	0.924%
5/15/2024	Bellevue Group AG	1,060	$0.28M	0.0%	N/A	0.005%
5/15/2024	Price T Rowe Associates Inc. MD	803,213	$214.49M	0.0%	+106.6%	3.769%
5/15/2024	Avoro Capital Advisors LLC	1,944,444	$519.24M	6.1%	+2.9%	9.125%
5/15/2024	University of Wisconsin Foundation	56,376	$15.06M	17.0%	-23.3%	0.265%
5/15/2024	Affinity Asset Advisors LLC	115,000	$30.71M	3.9%	+15.0%	0.540%
5/14/2024	Sheaff Brock Investment Advisors LLC	3,600	$0.96M	0.1%	N/A	0.017%
5/14/2024	Nan Fung Group Holdings Ltd	5,682	$1.52M	1.4%	+380.7%	0.027%
5/14/2024	EntryPoint Capital LLC	155	$41K	0.0%	N/A	0.001%
5/14/2024	Propel Bio Management LLC	43,032	$11.49M	6.4%	+43.3%	0.202%
5/14/2024	Pitcairn Co.	1,007	$0.27M	0.0%	N/A	0.005%
5/14/2024	American International Group Inc.	7,292	$1.95M	0.0%	-0.8%	0.034%
5/13/2024	Ameritas Investment Partners Inc.	1,476	$0.39M	0.0%	-3.7%	0.007%
5/10/2024	Vanguard Group Inc.	1,668,806	$445.64M	0.0%	+6.0%	7.840%
5/10/2024	Wintrust Investments LLC	19,270	$5.15M	0.5%	-6.1%	0.091%
5/9/2024	Lord Abbett & CO. LLC	97,103	$25.93M	0.1%	N/A	0.456%
5/9/2024	State Board of Administration of Florida Retirement System	3,577	$0.96M	0.0%	-8.0%	0.017%
5/8/2024	ProShare Advisors LLC	4,054	$1.08M	0.0%	+9.2%	0.019%
5/8/2024	Russell Investments Group Ltd.	5,488	$1.47M	0.0%	N/A	0.026%
5/7/2024	Sei Investments Co.	10,455	$2.79M	0.0%	-4.2%	0.049%
5/7/2024	Susquehanna Fundamental Investments LLC	2,186	$0.58M	0.0%	N/A	0.010%
5/7/2024	Swiss National Bank	23,400	$6.25M	0.0%	+9.3%	0.110%
5/7/2024	Oppenheimer & Co. Inc.	1,220	$0.33M	0.0%	N/A	0.006%
5/7/2024	SG Americas Securities LLC	1,347	$0.36M	0.0%	N/A	0.006%
5/3/2024	AlpInvest Partners B.V.	105,744	$28.24M	11.0%	-50.0%	0.497%
5/2/2024	Mutual of America Capital Management LLC	11,839	$3.16M	0.0%	-7.5%	0.056%
5/2/2024	BNP Paribas	255	$68K	0.0%	N/A	0.001%
5/1/2024	BNP Paribas Financial Markets	11,374	$3.04M	0.0%	-50.0%	0.057%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	92,253	$24.48M	0.0%	+50.0%	0.464%
4/30/2024	Allspring Global Investments Holdings LLC	381	$0.10M	0.0%	N/A	0.002%
4/29/2024	Principal Financial Group Inc.	4,002	$1.07M	0.0%	+3.3%	0.020%
4/29/2024	China Universal Asset Management Co. Ltd.	3,801	$1.02M	0.1%	+65.8%	0.018%
4/26/2024	UMB Bank n.a.	200	$53K	0.0%	N/A	0.001%
4/26/2024	First National Trust Co	3,544	$0.95M	0.0%	-19.7%	0.018%
4/24/2024	Newbridge Financial Services Group Inc.	11,033	$2.95M	1.3%	N/A	0.055%
4/24/2024	Assenagon Asset Management S.A.	12,958	$3.46M	0.0%	-32.1%	0.065%

Data available starting January 2016

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.

Today's Range

Now: $233.49

$233.00

$244.23

50 Day Range

MA: $255.47

$233.00

$287.24

52 Week Range

Now: $233.49

$119.76

$299.98

Volume

530,021 shs

Average Volume

440,606 shs

Market Capitalization

$4.98 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Madrigal Pharmaceuticals?: Madrigal Pharmaceuticals' top insider investors include:
Bros Advisors Lp Baker (Director)
Rebecca Taub (CMO)
Fred B Craves (Director)
Paul A Friedman (Director)
William John Sibold (CEO)
Brian Joseph Lynch (SVP)
Richard S Levy (Director)
Robert E Waltermire (VP)
James M Daly (Director)
Remy Sukhija (Insider)
Learn More about top insider investors at Madrigal Pharmaceuticals.
Who are the major institutional investors of Madrigal Pharmaceuticals?: Madrigal Pharmaceuticals' top institutional shareholders include:
Avoro Capital Advisors LLC — 9.47%
Paulson & CO. Inc. — 8.52%
Perceptive Advisors LLC — 1.24%
Susquehanna International Group LLP — 0.00%
Armistice Capital LLC — 0.69%
Fiera Capital Corp — 0.53%
Learn More about top institutional investors of Madrigal Pharmaceuticals stock.
Which major investors are selling Madrigal Pharmaceuticals stock?: During the last quarter, MDGL stock was sold by these institutional investors:
Susquehanna International Group LLP
Perceptive Advisors LLC
AlpInvest Partners B.V.
Hsbc Holdings PLC
Armistice Capital LLC
Hennion & Walsh Asset Management Inc.
Ensign Peak Advisors Inc
Assenagon Asset Management S.A.
Within the previous year, company insiders that have sold Madrigal Pharmaceuticals company stock include:
Bros Advisors Lp Baker (Director)
Rebecca Taub (CMO)
Fred B Craves (Director)
Paul A Friedman (Director)
William John Sibold (CEO)
Brian Joseph Lynch (SVP)
Richard S Levy (Director)
Robert E Waltermire (VP)
Learn More investors selling Madrigal Pharmaceuticals stock.
Which major investors are buying Madrigal Pharmaceuticals stock?: Within the last quarter, MDGL stock was purchased by institutional investors including:
Fiera Capital Corp
Avoro Capital Advisors LLC
Point72 Asset Management L.P.
Paulson & CO. Inc.
Fred Alger Management LLC
Sofinnova Investments Inc.
Bank of New York Mellon Corp
American Century Companies Inc.